Vol 6, No 1 (2015)
Review paper
Published online: 2015-05-14

open access

Page views 843
Article views/downloads 2032
Get Citation

Connect on Social Media

Connect on Social Media

New therapeutic targets in lymphoid malignancies — 5-year research perspective

Przemysław Juszczyński
DOI: 10.5603/Hem.2015.0010
Hematologia 2015;6(1):1-9.

Abstract

Translational studies on lymphoid malignancies have been, over the last 5 years, particularly intriguing and productive/fruitful. New discoveries have been fuelled by new technological research platforms, increasing computational powers, advances in bioinformatics and increasing academic-biotech/pharmaceutical partnerships. In some cases, this has led to vital advances in clinical practice where discoveries in epigenetic mechanisms were particularly significant in the regulation of human genome function, B-cell receptor signalling and tumour-associated immune escape mechanisms. It is very likely that the translational potential of these findings will thus be further developed in the future.




Hematology in Clinical Practice